Loading…
ClearPoint Neuro announced an agreement to acquire IRRAS Holdings, a San Diego-based medical technology company focused on neurocritical care, including the IRRAflow system for intracranial fluid management. The deal adds over 50 active customers and 10 patent families.
ClearPoint Neuro announced a multi-product joint development and option agreement with Blackrock Microsystems to develop products for neurosurgery markets, including microelectrode recording platforms and smart biopsy needles. Initial product launches are expected in 2023.